Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)
Johan Maertens(Universitair Ziekenhuis Leuven), Anne Thiebaut‐Bertrand(Délégation Paris 7), Anne Bergeron(Délégation Paris 7), Georg Maschmeyer(Radboud University Medical Center), Nicole M. A. Blijlevens(Radboud University Nijmegen), Annamaria Nosari(Università Cattolica del Sacro Cuore), Sibylle C. Mellinghoff(University of Cologne), Julien De Greef(Assistance Publique – Hôpitaux de Paris), Tomás Franquet(Radboud University Nijmegen)
Cited by 185
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k